Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endothelin and Ischemic Optic Neuropathy (bosentan vs placebo)
2014-000848-14Phase 3Active
- Sponsor
- CHU Grenoble Alpes
- Start
- Jun 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in non-arteritic anterior ischemic optic neuropathy (NAION) comparing Bosentan with Placebo (2 arms). Primary endpoint: Automated visual field at 3 months. Started Jun 2015; status: active.
02
Drugs
bosentan
03
Conditions
non-arteritic anterior ischemic optic neuropathy (NAION)
Beyond the preview
Go deeper on 2014-000848-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000848-14.